Joanne Wuensch
Stock Analyst at Citigroup
(2.4)
# 680
Out of 5,291 analysts
408
Total ratings
60.00%
Success rate
22.80%
Average return
Main Sectors:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Cooper Companies | Maintains: Buy | 115 110 | 83.77 | 31.31% | 18 | Mar 7, 2025 | |
Abbott Laboratories | Maintains: Strong Buy | 135 160 | 130.82 | 22.31% | 20 | Mar 4, 2025 | |
DexCom | Maintains: Strong Buy | 101 104 | 67.69 | 53.64% | 13 | Mar 4, 2025 | |
Sight Sciences | Maintains: Neutral | 5 3 | 2.55 | 17.65% | 10 | Mar 4, 2025 | |
Tandem Diabetes Care | Downgrades: Neutral | 35 24 | 19.25 | 24.68% | 14 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 92 107 | 87.61 | 22.13% | 17 | Mar 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Buy | 450 | 364.44 | 23.48% | 13 | Feb 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 310 355 | 258.63 | 37.26% | 14 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 103 110 | 79.97 | 37.55% | 3 | Feb 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 107 122 | 99.27 | 22.9% | 25 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 640 711 | 491.6 | 44.63% | 16 | Jan 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 200 245 | 266.95 | -8.22% | 24 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 6 5 | 5.85 | -14.53% | 19 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 185 175 | 163.6 | 6.97% | 12 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 130 145 | 117.07 | 23.86% | 4 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 81 83 | 70.9 | 17.07% | 19 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 37 35 | 33.76 | 3.67% | 18 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 17 8 | 6.82 | 9.97% | 10 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 24 22 | 14.18 | 55.15% | 4 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | 132 162 | 101.97 | 58.87% | 20 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Sell | 16 22 | 21.68 | 1.48% | 14 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 45 50 | 40.36 | 23.89% | 6 | Oct 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 135 110 | 105.05 | 4.71% | 17 | Aug 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 94 85 | 63.01 | 34.9% | 7 | Aug 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 134 120 | 112.23 | 6.92% | 22 | Jul 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Sell | 35 8 | n/a | n/a | 11 | Oct 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 63 52 | n/a | n/a | 10 | Feb 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Neutral | 220 250 | 227.36 | 9.96% | 5 | Dec 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 67 69 | 95.86 | -28.02% | 5 | Nov 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Outperform | 36 30 | n/a | n/a | 6 | Aug 8, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Outperform | 109 127 | 219.83 | -42.23% | 5 | Dec 10, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Market Perform | 65 40 | n/a | n/a | 5 | Aug 13, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | 245 0 | n/a | n/a | 2 | Apr 25, 2017 |